Literature DB >> 10896651

In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne.

C H Choe, S S Bouhaouala, I Brook, T B Elliot, G B Knudson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10896651      PMCID： PMC89957          DOI： 10.1128/AAC.44.6.1766-1766.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

Review 1.  Antibiotic resistance in bacteria. A current and future problem.

Authors:  H H Liu
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae.

Authors:  T A Davies; G A Pankuch; B E Dewasse; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 3.  Anthrax as a potential biological warfare agent.

Authors:  J C Pile; J D Malone; E M Eitzen; A M Friedlander
Journal:  Arch Intern Med       Date:  1998-03-09
  3 in total
  25 in total

1.  Biological Warfare: Implications for Antimicrobial Use.

Authors:  Ethan Rubinstein; Itzhak Levi
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

2.  Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.

Authors:  Jean-Didier Cavallo; Francoise Ramisse; Monique Girardet; Josée Vaissaire; Michelle Mock; Eric Hernandez
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

3.  Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.

Authors:  Henry S Heine; Jennifer Bassett; Lynda Miller; Bret K Purcell; W Russell Byrne
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

4.  A rapid antimicrobial susceptibility test for Bacillus anthracis.

Authors:  Linda M Weigel; David Sue; Pierre A Michel; Brandon Kitchel; Segaran P Pillai
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

Review 5.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria.

Authors:  Harry G Preuss; Bobby Echard; Mary Enig; Itzhak Brook; Thomas B Elliott
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

7.  MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest.

Authors:  Peter C B Turnbull; Nicky M Sirianni; Carlos I LeBron; Marian N Samaan; Felicia N Sutton; Anatalio E Reyes; Leonard F Peruski
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Small molecule inhibitors of anthrax lethal factor toxin.

Authors:  John D Williams; Atiyya R Khan; Steven C Cardinale; Michelle M Butler; Terry L Bowlin; Norton P Peet
Journal:  Bioorg Med Chem       Date:  2013-11-13       Impact factor: 3.641

9.  Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations.

Authors:  Patrick Grohs; Isabelle Podglajen; Laurent Gutmann
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

10.  Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity.

Authors:  Yu-hua Xing; Wei Wang; Su-qin Dai; Ti-yan Liu; Jun-jie Tan; Guo-long Qu; Yu-xia Li; Yan Ling; Gang Liu; Xue-qi Fu; Hui-peng Chen
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.